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Abstract 
The lipopeptide daptomycin has been reported to reduce in vivo the nephrotoxicity of aminoglycoside antibiotics (Wood et al. (1989) 
Antimicrob. Agents Chemother. 33, 1280-1285; Beauchamp et al. (1990) Antimicrob. Agents Chemother. 34, 139-147). A recent 
dialysis study confirmed the existence of an electrostatic interaction between daptomycin and tobramycin (Couture et al. (1994) 
Antimicrob. Agents Chemother. 38, 742-749). The interaction of gentamicin with daptomycin and phosphatidylinositol (PI) dispersions 
was investigated by FTIR spectroscopy. We found no evidence of a direct interaction involving the neutralization of the aspartate groups 
of daptomycin by gentamicin and the amide I band of daptomycin did not reveal significant conformational changes of its peptidic 
moiety. On the other hand, daptomycin readily inserts within bilayers of PI, dimyristoylphosphatidylglycerol or dipalmitoylphosphatidyl- 
choline, as judged from its influence on the fluidity of these bilayers. The incorporation of daptomycin to PI bilayers has no significant 
effect on the lipopeptide amide I band. Gentamicin also binds to PI bilayers and the associated modifications of the lipid bands are 
consistent with a tightening of the lipid network resulting from head group neutralization by gentamicin. The affinity of the 
aminoglycoside for PI is slightly increased in the presence of daptomycin, in agreement with the results of the dialysis study mentioned 
above. The lipid features indicate that its head group is still affected by gentamicin charges, but the thermotropic behavior of the 
hydrophobic portion becomes imilar to that of the pure lipid. It is proposed that the contribution of daptomycin to the membrane charge 
density and its effect on the lipid packing both combine to counteract the inhibition of phospholipase activity due to aminoglycosides. 
Further work will attempt to determine how the peptide rings and gentamicin molecules are organized at the bilayer surface, how specific 
these interactions are and to confirm the influence of daptomycin on the phospholipid catabolism. 
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1. Introduction 
The aminoglycosidic antibiotic gentamicin (Fig. 1A) is 
widely used to treat infections caused by Gram-negative 
bacteria [ 1]. Unfortunately, aminoglycosides may also yield 
oto-and nephrotoxic reactions. The higher susceptibility of 
kidney and inner ear cells seems to be related to the 
presence of high concentrations of phosphatidylinositols in 
their cytoplasmic membranes [2]. The existence of specific 
biochemical interactions of aminoglycosides with their tar- 
get cells has been suggested [2]. Aminoglycosides are not 
Abbreviations: DMPG, dirnyristoylphosphatidylglycerol; DPPC, 
dipalmitoylphosphatidylcholine; PI, phosphatidylinositol. 
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metabolized and are eliminated from the body by the 
kidney only. The resulting high concentrations of these 
drugs in the glomerular filtrate promote their nephrotoxic- 
ity. 
The first step in the mechanism leading to aminoglyco- 
side-induced acute renal failure is the binding of the 
positively charged antibiotic to anionic lipids on brush 
border membranes [3,4] and possibly also on basolateral 
membranes. Phosphatidylinositides have been proposed to 
be the receptors for aminoglycosides on brush border 
membranes [5]. The reabsorption then occurs through 
pinocytosis, followed by fusion of the endocytotic vac- 
uoles with primary lysosomes. The aminoglycoside accu- 
mulates within lysosomes and inhibits phospholipases and 
sphingomyelinase activity [6,7], causing the formation of 
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myeloid bodies. The growth of these tightly apposed li- 
pidic bilayers is believed to result in swelling of the 
lysosomes and ultimately in their bursting and the release 
of large amounts of aminoglycoside, lysosomal enzymes 
and phospholipids into the cytosol. Necrosis of proximal 
tubular cells follows, leading to impairment of renal func- 
tion. In fact, a recent immunocytochemical study of the 
subcellular distribution of gentamicin showed that the drug 
distributed in the cytoplasm, in the mitochondria and in the 
nucleoli of necrotic proximal tubular cells [4]. Owing to 
the remarkable regenerative properties of kidney cells, this 
impairment is usually reversible upon cessation of treat- 
ment. Nevertheless, the reduction of aminoglycoside 
nephrotoxicity remains a concern among clinicians and 
various strategies are being explored to reduce it. Oral 
supplementation f calcium has been found to reduce 
gentamicin ephrotoxicity, the cation acting as a competi- 
tive inhibitor of the drug on renal membrane binding sites 
[8,9]. The applicability of calcium supplementation for 
clinical use is questionable since high amounts are re- 
quired to get protection. Latamoxef, an oxacephem antibi- 
otic, has been shown to protect rat from nephrotoxicity 
induced by the aminoglycoside tobramycin. Latamoxef 
reduces tobramycin intrarenal level [10] by inhibiting its 
binding to brush border membranes [11]. It has been 
shown to react chemically with tobramycin in vitro [12]. 
Pyridoxal 5'-phosphate (vitamin B-6) also protects against 
gentamicin induced nephrotoxicity by mechanisms similar 
to latamoxef [13]. On the other hand, a protection of renal 
function can also be afforded without any reduction of 
aminoglycoside cortical level. Hence, coadministration f 
polyaspartic acid with gentamicin prevented functional 
renal failure [14-18] in spite of up to 10-fold increase of 
the level of accumulated aminoglycoside [16]. A reduction 
of lysosomal phospholipidosis was noted and the usual 
post-necrotic aminoglycoside-induced increase in DNA 
synthesis was prevented [18]. The polyamino acid was 
found to bind gentamicin and to displace it from anionic 
phospholipids in vitro [19]. The clinical use of polyaspartic 
acid needs to be assessed. 
Daptomycin (Fig. IB) has been proposed as an alterna- 
tive to vancomycin, [20,21] a glycopeptidic antibiotic used 
in combination with aminoglycosides to enhance their 
bactericidal activity but which also aggravates their 
nephrotoxicity [6,22,23]. Daptomycin, formerly known as 
LY146032, is a lipopeptidic antibiotic active against 
Gram-positive bacteria in which it inhibits lipoteichoic 
acid synthesis. Daptomycin has been found to prevent he 
development of aminoglycoside-induced functional renal 
failure [24]. Similar to polyaspartic acid, it inhibited lyso- 
somal phospholipidosis and increased cellular egeneration 
in the presence of similar or even higher aminoglycoside 
levels [6]. The mechanism for this inhibition is still un- 
known and the present spectroscopic nvestigation is an 
attempt to address this question. We are thus searching for 
spectral indications of (i) a direct interaction between 
daptomycin and gentamicin in solution and of (ii) a possi- 
ble influence of daptomycin on gentamicin binding to 
lipidic membranes. Bilayers of phosphatidylinositol are 
used as model membranes because gentamicin binds pref- 
erentially to that lipid. 
2. Materials and methods 
The sodium salt of L-a-phosphatidylinositol fr m soya 
bean was obtained from Sigma (St. Louis, MO). Gentam- 
icin was kindly donated by Schering Canada (Pointe-Claire, 
Qurbec, Canada) whereas daptomycin was a generous gift 
of Eli-Lilly Canada (Scarborough, Ontario, Canada). 
Deuterated water was from MSD Isotopes (Montrral, 
Qurbec, Canada). The lipidic dispersions (10 wt%) were 
prepared in H20 or  2H20 with at least three freeze-thaw 
cycles. Additional freeze-thaw cycles were also performed 
after additions of the required amount of 5% gentamicin 
solution and 10% daptomycin solution in H20 or 2H20, 
after appropriate pH adjustment by addition of minimal 
amounts of HCl or NaOH (or 2HCI/NaO2H), as required. 
Infrared spectra were obtained at room temperature ona 
Digilab FTS-40 Fourier-transform spectrometer. A total of 
256 interferograms were co-added for each spectrum, with 
a spectral resolution of 2 cm -~. Experiments at variable 
temperature were realized on a Digilab FTS-60 Fourier- 
transform spectrometer equipped with a thermostatted bath, 
with an equilibration period of 7 rain after reaching each 
temperature. Data treatment was performed as described 
earlier [25]. 
3. Results 
Infrared spectroscopy is an excellent technique to probe 
molecular interactions because the vibrational modes that 
are examined are often affected by changes in molecular 
segment conformation, charge and hydrogen bonding. The 
simplest hypothesis to explain the protection afforded by 
daptomycin against gentamicin ephrotoxicity is a direct 
interaction of the two oppositely charged species in solu- 
tion, resulting in an impairment of the aminoglycoside 
binding to brush border membranes. 
3.1. Direct interaction of daptomycin and gentamicin 
Gentamicin (Fig. I A) has a very simple infrared spec- 
trum. Below 2000 cm- J, it comprises a single well defined 
band, at approx. 1103 cm-I (Fig. 2). This band contains 
contributions from many vibrations, in particular C-N 
stretching from the primary and secondary amine groups, 
C-O stretching and C-C stretching. This composite band 
remains the same at pH 7.5 and 5.4. This latter is the pH 
found in lysosomes, where gentamicin accumulates in 
kidney cells [26]. The contributions of C-N, C-O and C-C 
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Fig. 1. Chemical structure of gentamicin C IA (A) and of daptomycin (B). 
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Fig. 3. Carbonyl stretching region of the infrared spectra of daptomycin 
alone (solid line) or with gentamicin (dashed line) in solution, at a 
gentamicin/daptomycin molar atio of 2:1 in aqueous solutions, at pH 
5.4 (left panels) and 7.5 (right panels). The original spectra (A and B) 
were deconvolved using a bandwith of 13 and a breakpoint of 1.75 (C 
and D). 
stretching vibrations of daptomycin in that region do not 
give rise to a well defined band. The addition of dapto- 
mycin to gentamicin does not result in any significant 
alteration of the frequency or overall shape of gentamicin 
1103 cm-  ~ band at either pH. 
The lipopeptide daptomycin (Fig. IB) contains many 
features that can be sensitive to changes in conformation 
or ionization of the molecules. The 3-methyl glutamate and 
the three aspartate side chains confer a net negative charge 
on the molecule at neutral pH. The carbonyl stretching 
vibrations of these groups give a band of moderate inten- 
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Fig. 2. Infrared spectrum of gentamicin in the C-O, C-C and C-N 
stretching region at pH 5.4 (A) and 7.5 (B). Solid lines represent aqueous 
solutions of gentamicin a d dashed lines, aqueous solutions of gentamicin 
in the presence ofdaptomycin at a gentamicin/daptomycin molar atio of 
2:1. Spectral contributions of daptomycin have been subtracted. 
sity at 1580 cm -1 at both pH 5.4 and 7.5, consistently 
with the prevalence of the ionized state in that pH interval 
(Fig. 3A, solid line). At lower pH, the carboxylate band 
loses intensity and the protonated acid band grows up at 
1710 cm - j .  Another carbonyl stretching band is also 
found at approx. 1744 cm-1 at all pH values. This peak is 
probably due to the C = O stretching vibration of the ester 
function of the peptidic ring and of the aromatic ketone 
group of the L-kynurenine residue. This feature is of little 
diagnostic value. On the other hand, the amide I band seen 
at 1649 cm ~ is known to be sensitive to peptide back- 
bone conformation. In proteins and polypeptides, its shape 
and frequency are used to characterize secondary structure. 
The cyclic structure of daptomycin peptidic portion 
severely restrains the backbone flexibility and impedes the 
formation of sufficiently long a-helices or /3-sheets for 
example. Nevertheless, interactions at the side chains and 
changes in environment can still be reflected in spectral 
variations of the amide I band because they can affect the 
backbone geometry. The shape and frequency of the amide 
I band are not affected upon going from pH 5.4 to 7.5 and 
addition of gentamicin also fails to induce any significant 
changes (Fig. 3). 
Although the neutralization of a fraction of the carbox- 
ylate groups produced upon lowering the pH from 7.5 to 
5.4 was reflected in a marked decrease of the intensity of 
the band at 1579 cm-  t, no consistent change of that band 
was noted when gentamicin was added. If there is an 
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electrostatic nteraction between daptomycin and gentam- 
icin, it can only be a loose one, extending through the 
hydration spheres of these molecules and causing no con- 
straints on their conformation. 
3.2. Effect of gentamicin on phosphatidylinositol bi ayers 
To better judge the effect of daptomycin on gentam- 
icin-PI interaction, we must first characterize this latter. 
The lipid spectrum contains two useful features in this 
regard: its carbonyl stretching band and its phosphate 
antisymmetric stretching band, both occurring in spectral 
regions free of gentamicin contributions. 
The carbonyl stretching band of the ester functions of 
phosphatidylinositol in aqueous uspension is presented in 
Fig. 4. The original spectrum, consisting of an asymmetric 
band. reveals two components after resolution enhance- 
ment using Fourier self-deconvolution (Fig. 4A and B, 
solid line) [25]. The high frequency component, at 1745 
cm -~, pertains to carbonyl groups that are not hydrogen 
bonded and the peak at 1725 cm-~ corresponds to hydro- 
gen bonded carbonyl groups. The addition of gentamicin to 
PI suspension in a molar ratio of 2 PI /1 gentamicin does 
not result in any significant frequency shift of these two 
components, but an increase of the intensity ratio of non 
bonded to bonded carbonyl bands is observed (Fig. 4, 
small dashes). Gentamicin thus induces an increase in the 
proportion of carbonyl groups that are not hydrogen 
bonded. Replacing the solvent 2H20 by H20 resulted in a 
1 cm-~ increase in the frequency of hydrogen bonded 
carbonyl band while the free carbonyl component re- 
mained unaffected (not shown). This frequency shift indi- 
cates that the carbonyl hydrogen bonding involves solvent 
molecules. The decrease in the population of hydrogen 
bonded carbonyl groups shows that gentamicin reduces the 
penetration of water to the bilayer interface region. It is 
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Fig. 4. Carbonyl stretching region of the infrared spectra of dispersions of 
phosphatidylinositol in 2H20 at p2H 5.4 (A) and 7.5 (B). The spectrum 
of a dispersion of the pure lipid (solid trace) is compared to that of 
dispersions containing entamicin (small dashes) at a Pl/gentamicin 
molar atio of 2:1, daptomycin (long dashes) at a PI/daptomycin molar 
ratio 4:1 or both gentamicin and daptomycin (dot-long dash) at a 
Pl/gentamicin/daptomycin molar atio 4:2:1. The spectra were obtained 
after resolution enhancement using Fourier self-deconvolution with a 
bandwith of 13 and a breakpoint of 1.5. 
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Fig. 5. Phosphate antisymmetric stretching region of the infrared spectra 
of aqueous dispersions ofphosphatidylinositol al ne (solid line) or with 
gentamicin (small dashes) at a Pl/gentamicin molar atio of 2:1, dapto- 
mycin (long dashes) at a PI/daptomycin molar atio of 4:1 or both 
gentamicin and daptomycin (dot-long dash) at a 
PI/gentamicin/daptomycin molar atio of 4:2:1, at pH 5.4 (A) and 7.5 
(B). 
consistent with a tightening of the lipidic network follow- 
ing neutralization of PI molecules by gentamicin. The 
same behavior is observed at p2H 5.4 and 7.5. Ramsammy 
and Kaloyanides observed a gentamicin-induced decrease 
of glycerol permeability of DPPC/PI  liposomes at pH 7.0 
and related it to such a tightening of the lipidic network 
[27]. They also reported an increase of the activation 
energy for glycerol permeation and suggested that it might 
result from hydrogen bonding between some amino groups 
of gentamicin and the lipid carbonyl ester groups. That 
explanation is not consistent with our finding that gentam- 
icin induces a decrease of the proportion of hydrogen 
bonded carbonyl groups. 
The phosphate region must be studied in the absence of 
2H20 to avoid interferences from its bending mode in the 
1200 cm-1 region. The frequency of the phosphate anti- 
symmetric stretching vibration usually varies between 1220 
and 1270 cm-l ,  depending on the extent of hydrogen 
bonding [28]. A lipidic dispersion of PI yielded a broad 
band with a maximum at 1216 cm -~ (Fig. 5A and B, solid 
line), for both pH 5.4 and 7.5. The addition of gentamicin 
resulted in a decrease of approx. 2 cm- ~ of the frequency 
of the maximum of that band, irrespective of pH (Fig. 5A 
and B, small dashes). Actually, this frequency shift seems 
to result mostly from a marked ecrease of the intensity on 
the high frequency side of the broad band, corresponding 
to lipid molecules with weaker hydrogen bonds. The fre- 
quency shift was smaller for a molar ratio of 8 PI/1 
gentamicin instead of 2:1. The strengthening of phosphate 
hydrogen bonds is also consistent with a decrease of PI 
intermolecular distance resulting from charge neutraliza- 
tion by gentamicin. 
3.3. Effect of daptomycin on phosphatidylinositol bi ayers 
Daptomycin bears a net negative charge which pre- 
cludes electrostatic binding to PI bilayers. There should 
rather be electrostatic repulsion. On the other hand, the 
long decanoyl chain of the lipopeptide will also give rise 
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Fig. 6. Temperature dependence of the frequency of the symmetric C-H 
stretching vibration of the methylene groups of PI (A), DMPG (B) and 
DPPC (C) and of the frequency of the C-H stretching vibration of the 
olefinic groups of PI (D) in aqueous dispersions, in the absence (circles) 
and in the presence (triangles) of daptomycin at a lipid/daptomycin 
molar ratio of 2:1 at preparation, p2H 5.4. The coordinates on the right 
side of panels A and D apply to triangles. 
to an entropy-driven hydrophobic effect. In other words, 
the lipidic character of daptomycin could dominate the 
thermodynamic balance of forces and lead to the insertion 
of the decanoyl chain within the hydrophobic ore of PI 
bilayer, in spite of repulsion between the peptidic ring and 
PI head groups. 
If the decanoyl chain of daptomycin does insert within 
the hydrophobic ore of PI bilayers, it should affect the 
properties of this latter. Soya bean PI contains a mixture of 
various acyl chains, the most common being palmitate 
(16:0) and linoleate (18:2) [29]. This heterogeneity abol- 
ishes cooperativity in the gel-to-fluid transition: the fluid- 
ity of the hydrophobic core increases gradually with tem- 
perature. The frequency of the C-H stretching modes can 
be used to probe membrane fluidity. It can be seen on Fig. 
6A (circles) that the frequency of the symmetric C-H 
stretching vibration of the methylene groups of PI lipo- 
somes increases gradually upon raising the temperature 
from 5 to 60 ° C. The frequency of that mode changes 
dramatically at the gel-to-fluid transition for bilayers of 
lipids containing homogeneous acyl chains, like dimyris- 
toylphosphatidylglycerol (DMPG) (Fig. 6B, circles) and 
dipalmitoylphosphatidylcholine (DPPC) (Fig. 6C, circles). 
If the driving force in the interaction of daptomycin 
with PI is a hydrophobic effect, then the lipopeptide is 
likely to undergo the same type of interaction with any 
type of phospholipidic bilayers. Indeed, daptomycin in- 
duces a 5°C decrease of the transition temperature of 
DMPG bilayers (Fig. 6B, triangles) and a 7 ° C decrease of 
that of DPPC bilayers (Fig. 6C, triangles), as well as a 
decrease of the cooperativity and amplitude of that transi- 
tion. The decanoyl chain of daptomycin is shorter than 
myristoyl and palmitoyl chains, so its insertion into the 
bilayer hydrophobic core impedes a perfect packing of the 
acyl chains on their entire length and consequently destabi- 
lizes the gel phase. Owing to the broadness of PI transi- 
tion, the disordering effect of daptomycin i sertion is more 
subtle and difficult to detect in the temperature profile of 
the methylene symmetric stretching vibration (Fig. 6A). 
The ordinate scales have been adjusted to match both ends 
of the profiles in order to facilitate comparisons of overall 
shapes. In the presence of daptomycin, PI gets disordered 
faster, that is to say at a lower temperature. Interestingly, 
the effect of daptomycin is more pronounced when moni- 
tored using the frequency of the C-H stretching mode of 
alkenyl groups. The double bonds of linoleyl chains are 
found at positions 9 and 12, which are most likely located 
below the terminal methyl group of daptomycin. That 
inner region of the bilayer core experiences the greatest 
disordering effect because the space between PI acyl chains 
is larger at that level when daptomycin is present in the 
upper part. Moreover, the acyl chain portion adjacent o 
the decanoyl chain of daptomycin is being compressed and 
its order is actually increased. The methylene stretching 
frequency reflects an average of the properties of upper 
and deeper regions whereas the alkenyl stretching fre- 
quency probes only the inner region, where the disturbing 
influence of daptomycin is maximal. 
The insertion of daptomycin into PI bilayers may also 
affect he lipid head group and interface. The frequency of 
the two components of PI carbonyl stretching band, ob- 
tained after derivatization of the original spectra, are not 
affected by daptomycin. A small increase of the proportion 
of non hydrogen bonded carbonyl groups is observed at 
both pH 5.4 and 7.5 (Fig. 4A and B, long dashes), 
suggesting that the insertion of daptomycin results in a 
tightening of the bilayer at the interface level. 
The phosphate antisymmetric stretching band is slightly 
shifted to higher frequencies (Fig. 5A and B, long dashes), 
by approx. 1 cm -1 . This could be due to steric constraints 
put on the head group by the bulky peptidic moiety of 
daptomycin. Actually, an apparent narrowing of the amide 
I band of this latter is observed in the presence of PI (Fig. 
7C and D, long-short dashes), but the subtraction of the 
spectral contribution of the C = C stretching mode of PI 
linoleyl chains (dot-long dash) yields a band (long dashes) 
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Fig. 7. Amide I region of the infrared spectra of daptomycin (solid line) 
in ~H20 at p2H 5.4 (left panels) or 7.5 (right panels). Gentamicin has no 
contribution i  that spectral region (A and B, long dashes). The amide I
band of daptomycin in the presence of gentamicin at a 
gentamicin/daptomycin molar ratio of 2:1 appear in small dashes (A and 
B). The spectra of daptomycin i the presence of PI, at a PI/daptomycin 
molar ratio of 4:1, are given in C and D (short-long dashes). However, PI 
does contribute in that region (C-F, dot-long dash) and this spectral 
contribution has been subtracted to give the actual amide I band of 
daptomycin in the presence of PI (C and D, long dashes). The original 
spectra of PI/gentamicin/daptomycin at a molar ratio of 4:2:1 (E and F, 
short-long dashes) has also been corrected for PI contribution and the 
corrected aptomycin spectra re given in long dashes (E and F). 
that is almost superimposable to that of daptomycin alone 
(solid line). 
3.4. Effect of daptomycin on gentamicin-phosphatidyl- 
inositol interaction 
Gentamicin acts as a polycation with PI bilayers. Its 
addition to a dispersion of this negatively charged lipid 
results in a fast and massive aggregation. The formation of 
these big, flaky aggregates is due to the binding of gentam- 
icin to bilayers from different liposomes. Daptomycin also 
causes PI precipitation, but the aggregates are not bulky. A 
clear supernatant, free of PI, is also obtained. We checked 
for the presence of the antibiotics in the supernatant, using 
the C-O and C-N stretching band (1103 cm -1) as a rough 
estimate of gentamicin concentration a d the amide I band 
for daptomycin monitoring. It was an easy test to see if the 
presence of daptomycin within PI bilayers would impede 
or affect in any way gentamicin binding or if premixing of 
daptomycin and gentamicin would prevent he fixation of 
the aminoglycoside on the lipidic surface. Surprisingly, we 
consistently found slightly less gentamicin in the super- 
natant in samples containing daptomycin (not shown). All 
mixtures presented spectral evidences of large amounts of 
both antibiotics in the precipitate. Therefore, daptomycin 
does not impede the binding of gentamicin to phospha- 
tidylinositol. Infrared spectroscopy can be used to charac- 
terize the ternary complex of gentamicin-daptomycin-PI. 
The lipid carbonyl stretching region of the infrared 
spectrum of PI-gentamicin-daptomycin at a molar ratio of 
4:2:1 is presented in Fig. 4C. At both pH 5.4 and 7.5, there 
is a more pronounced ecrease of hydrogen bonded PI 
carbonyl groups than in the presence of gentamicin only. 
The result is essentially the same if daptomycin is added 
after or before gentamicin, or if they are mixed prior to 
addition to PI dispersion. As for PI-daptomycin and PI- 
gentamicin mixtures, there is no significant shift of the 
frequency of the two carbonyl stretching components. It
thus appears that hydrogen bonding of PI carbonyl groups 
still involves solvent molecules, but the proportion of 
bonded groups is smaller because gentamicin and dapto- 
mycin work in conjunction to tighten up the lipidic net- 
work, squeezing out more water molecules. The basic 
factor, of course, is charge neutralization f PI head groups. 
As described above, daptomycin causes a high fre- 
quency shift of the antisymmetric stretching bands of PI 
phosphate group whereas gentamicin i duces a decrease of 
its frequency and bandwidth at both pH 5.4 and 7.5 (see 
Fig. 5). In the presence of both gentamicin and dapto- 
mycin, there is a low frequency shift similar to that 
obtained with gentamicin alone but of a smaller magnitude 
(Fig. 5A and B, dot-long dash). 
The spectral changes analyzed up to this point are 
consistent with an additivity of effects of daptomycin and 
gentamicin. The presence of the bulky peptidic loop of 
daptomycin at the bilayer surface does not prevent subse- 
quent binding of gentamicin and conversely, daptomycin 
interacts with the bilayer in spite of prior treatment with 
gentamicin. The slower aggregation observed when pre- 
mixed gentamicin and daptomycin are added to PI disper- 
sions suggests that achieving appropriate spatial organiza- 
tion of the three components i an arduous task. It may 
explain also why the spectra re not as reproducible for the 
ternary mixtures. The steric constraints between the gen- 
tamicin molecules adsorbed onto the lipidic surface and 
the peptidic rings extending out of the bilayer can possibly 
result in conformational changes of the peptidic portion. 
The amide I region of the infrared spectrum of daptomycin 
is presented in Fig. 7 (solid line). As discussed above, 
gentamicin alone does not affect the amide I band of 
daptomycin and this latter is not significantly affected 
when daptomycin inserts in a lipidic environment. How- 
ever, the width of the amide I band is slightly reduced in 
the ternary complex, once the lipid contribution has been 
subtracted (Fig. 7E and F, long dashes). This shallow 
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Fig. 8. Temperature dependence of the frequency of the symmetric C-H 
stretching vibration of the methylene groups of PI (A) and of the 
frequency of the C-H stretching vibration of the olefinic groups of PI (B) 
in aqueous dispersions, in the absence (circles) and in the presence 
(triangles) of both gentamicin and daptomycin at a 
lipid/gentamicin/daptomycin molar ratio of 4:2:1 at preparation, p2H 
5.4. The coordinates on the fight side of panels A and B apply to 
triangles. 
effect probably reflects the accommodation f the peptide 
to the steric constraints imposed by gentamicin on dapto- 
mycin. 
As described earlier, the insertion of the decanoyl chain 
of daptomycin into the hydrophobic ore of PI bilayers 
results in an increased order of the portion of the acyl 
chain that is adjacent o the lipopeptide decanoyl chain, 
whereas the terminal portion of the long lipidic acyl chain 
becomes more fluid. Gentamicin i duces a rigidification of 
PI bilayers. A decrease in the fluidity of the membrane 
was also observed in the presence of the aminoglycoside 
drug (data not shown), in agreement with observations 
made with PC/PI mixtures by differential scanning 
calorimetry [27] or with brush-border membranes, using 
electron spin resonance [30]. When both daptomycin and 
gentamicin are present, the effect disappears and the tem- 
perature dependence of the frequency of the methylene 
symmetric stretching mode of the lipid acyl chains in 
samples with and without he mixture of both antibiotics i  
identical, as seen in Fig. 8. 
4. Discussion 
Because of the lack of satisfactory alternative drugs, 
aminoglycosides are still essential for the treatment of 
severe infections. Various strategies are currently evalu- 
ated to reduce the clinical occurrence of aminoglycoside- 
induced acute renal failure. The aim of this spectroscopic 
investigation is to shed some light on the mechanism by 
which daptomycin i hibits gentamicin ephrotoxicity. 
A recent dialysis study indicated a direct interaction of 
daptomycin with the aminoglycoside tobramycin [31]. The 
dependence on ionic strength confirmed the electrostatic 
character of this interaction. Interestingly, the results 
showed an increased binding of tobramycin after incorpo- 
ration of daptomycin i to liposomes containing PI. In the 
present study, we found no spectral evidence of a direct 
interaction of daptomycin with gentamicin i solution. The 
absence of significant spectral changes and the fact that 
both compounds remain in solution after mixing preclude 
tight interactions and direct neutralization f daptomycin's 
carboxylates. Nevertheless, the formation of a loose com- 
plex cannot be excluded, it would justify the dialysis 
results and still be compatible with our spectroscopic 
study. 
The postulated electrostatic nteraction of daptomycin 
with gentamicin solution does not prevent the binding of 
the aminoglycoside with PI. Its inhibitory mechanism is
thus different han that of latamoxef [11] and pyridoxal 
5'-phosphate [13]. In contrast with these previous results, 
our results indicate that daptomycin promotes gentamicin 
binding to PI bilayers. Once again, this finding is in 
agreement with the dialysis study mentioned above [31]. It 
also relates to in vivo results showing that daptomycin 
protects proximal tubular cells from tobramycin induced 
nephrotoxicity without reducing tobramycin cortical evels 
[6,24]. Beauchamp and coll. found that despite similar or 
higher amounts of aminoglycosides in the lysosomes, dap- 
tomycin inhibited aminoglycoside-induced lysosomal 
phospholipidosis [6]. The dialysis results indicate that the 
interaction between tobramycin and membranes containing 
daptomycin and PI was actually stronger at lysosomal pH, 
that is 5.4, than at pH 7.4. This raises one question: if the 
sequestration f PI by gentamicin prevents the lipid from 
activating phospholipases and consequently leads to phos- 
pholipidosis, then how could PI play its role of activator 
when it is involved in a tighter complex with daptomycin 
and the aminoglycoside? The organization of the complex 
with daptomycin must be clarified. A recent deuterium 
nuclear magnetic resonance study reported that the most 
toxic aminoglycosides induce a greater perturbation of the 
acyl chains in PC-PI mixtures [32]. The results were 
consistent with the formation of PI enriched omains after 
binding of the most toxic aminoglycosides, whereas less 
toxic aminoglycosides would not lead to lipid phase sepa- 
ration. Both the formation of PC enriched areas and the 
neutralization of PI charges can interfere with the activity 
of phospholipases. The binding of phospholipase A 2 to 
phospholipidic membranes requires the presence of nega- 
tively charged lipids [33,34] and perturbations of the charge 
distribution can result in a dramatic reduction of their 
binding [35]. 
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The spectroscopic data presented here revealed a few 
features about the interactions of daptomycin with PI and 
PI + gentamicin. Owing to the hydrophobic character con- 
ferred by its decanoyl chain, daptomycin does incorporate 
into lipidic membranes, notwithstanding the repulsion be- 
tween its peptidic moiety and the negatively charged head 
groups of DMPG or PI. The insertion of the short decanoyl 
chain of daptomycin molecules in the hydrophobic core of 
the bilayer results in an increased order of the portion of 
the acyl chains that is adjacent o the decanoyl chains, 
whereas the terminal portion of the long lipidic acyl chains 
(mostly palmitate and linoleate) becomes more fluid. On 
the other hand, the conformation of the peptidic moiety of 
daptomycin experiences no significant alteration, as seen 
from its amide I band (Fig. 7). When gentamicin is also 
present, this latter indicates a slight change of the peptide 
conformation. With the data available, it is impossible to 
determine how the peptide rings and gentamicin molecules 
are organized at the bilayer surface. Obviously, their inter- 
action is stronger in a membrane nvironment than when 
both are free in solution. The nephroprotection afforded by 
daptomycin may involve two elements. The negative 
charges located on the hydrophilic peptide moiety increase 
the charge density at the membrane surface, thus promot- 
ing the binding of the phospholipase molecules. Secondly, 
the rate of hydrolysis of these enzymes is very sensitive to 
the lipid packing in the bilayer and falls drastically as the 
temperature departs from the gel-to-fluid phase transition 
temperature [36]. Gentamicin induces an increase of the 
transition temperature of pure lipids and rigidities PI bilay- 
ers, but daptomycin creases the disorder in the inner core 
of the hydrophobic region and thus affects the lipid pack- 
ing. This could also promote substrate binding to the 
phospholipases. 
5. Conclusions 
The nephroprotection provided by daptomycin does not 
involve a reduced affinity of the aminoglycoside for PI but 
it can be related to changes in the physical properties of 
the bilayer. We propose that daptomycin counteracts the 
inhibition of phospholipase activity due to gentamicin by 
restoring the critical charge density and distribution re- 
quired for optimal enzyme activity and by affecting the 
lipid packing. 
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